Immuron (IMRN) Other Non-Current Liabilities (2017 - 2025)
Immuron (IMRN) recorded quarterly Other Non-Current Liabilities of $718.55 in Q3 2025, down 98.44% quarter-over-quarter from $46018.3 in Q2 2025, and down 45.95% on a YoY basis from $1329.4 in Q3 2024.
Immuron (IMRN) Other Non-Current Liabilities (2017 - 2025) Analysis & Trends
Immuron's Other Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $718.55 for Q3 2025.
- In Q3 2025, Other Non-Current Liabilities fell 45.95% year-over-year to $718.55; the TTM figure through Sep 2025 stood at $718.55 (down 45.95% YoY), while the FY2025 annual figure was $718.55, down 45.95% from the prior year.
- Other Non-Current Liabilities was $718.55 for Q3 2025 at Immuron, down from $46018.3 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $125641.3 in Q2 2022 to a low of $718.55 in Q3 2025.
- Historically, Other Non-Current Liabilities has averaged $58597.7 across 5 years, with a median of $60448.5 in 2024.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities soared 8066.27% in 2022, then sank 99.26% in 2023.
- A 5-year view of Other Non-Current Liabilities shows it stood at $1411.3 in 2021, then soared by 8066.27% to $115248.9 in 2022, then tumbled by 99.26% to $848.08 in 2023, then jumped by 7027.65% to $60448.5 in 2024, then tumbled by 98.81% to $718.55 in 2025.
- The last three Other Non-Current Liabilities figures came in at $718.55 (Q3 2025), $46018.3 (Q2 2025), and $60448.5 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 718.55 |
| Jun 30, 2025 | 46,018.33 |
| Dec 31, 2024 | 60,448.48 |
| Sep 9, 2024 | 1,329.41 |
| Jun 30, 2024 | 87,611.37 |
| Dec 31, 2023 | 848.08 |
| Sep 28, 2023 | 98,535.00 |
| Aug 30, 2023 | 1,503.25 |
| Jun 30, 2023 | 100,471.28 |
| Dec 31, 2022 | 115,248.85 |
| Aug 31, 2022 | 121,984.82 |
| Jun 30, 2022 | 125,641.34 |
| Dec 31, 2021 | 1,411.28 |
| Sep 1, 2020 | 18,929.00 |
| Jun 30, 2020 | 12,406.46 |
| Dec 31, 2019 | 189.29 |
| Dec 31, 2017 | -914,807.89 |